Literature DB >> 10209522

Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)--relation to Th1- and Th2-derived cytokines.

Y Tokano1, S Morimoto, H Kaneko, H Amano, K Nozawa, Y Takasaki, H Hashimoto.   

Abstract

IL-12 is a cytokine that induces Th1-derived cytokines (interferon-gamma (IFN-gamma) and IL-2). The significance of IL-12 in human autoimmunity is no clear, and the serum levels of IL-12 in SLE are not clearly established. Therefore, we examined the levels of IL-12 in 39 patients with active SLE, with sandwich ELISA. The levels of IL-12 in patients were significantly higher than in normal subjects. Patients with high levels of IL-12 also had high levels of IFN-gamma, while their levels of IL-13 were significantly lower than in patients with normal levels of IL-12. Patients with pulmonary involvement had high levels of IL-12, and steroid therapy decreased the IL-12 level in three patients. In a retrospective study of seven patients, various changes of IL-12 and IL-13 were recognized before disease flare. Thus, in SLE patients, the level of IL-12 was increased and this increase was related to the change of Th1- or Th2-derived cytokines with some organ involvement.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10209522      PMCID: PMC1905207          DOI: 10.1046/j.1365-2249.1999.00862.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

Review 1.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

2.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

Authors:  C Bombardier; D D Gladman; M B Urowitz; D Caron; C H Chang
Journal:  Arthritis Rheum       Date:  1992-06

3.  Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis.

Authors:  M Linker-Israeli; R J Deans; D J Wallace; J Prehn; T Ozeri-Chen; J R Klinenberg
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

4.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

5.  Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses.

Authors:  A Minty; P Chalon; J M Derocq; X Dumont; J C Guillemot; M Kaghad; C Labit; P Leplatois; P Liauzun; B Miloux
Journal:  Nature       Date:  1993-03-18       Impact factor: 49.962

6.  Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus.

Authors:  Y P Huang; L H Perrin; P A Miescher; R H Zubler
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

7.  In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas.

Authors:  C Reis e Sousa; S Hieny; T Scharton-Kersten; D Jankovic; H Charest; R N Germain; A Sher
Journal:  J Exp Med       Date:  1997-12-01       Impact factor: 14.307

8.  Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells.

Authors:  G Le Gros; S Z Ben-Sasson; R Seder; F D Finkelman; W E Paul
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

9.  Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.

Authors:  M Kobayashi; L Fitz; M Ryan; R M Hewick; S C Clark; S Chan; R Loudon; F Sherman; B Perussia; G Trinchieri
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

10.  Recombinant interleukin 12 cures mice infected with Leishmania major.

Authors:  F P Heinzel; D S Schoenhaut; R M Rerko; L E Rosser; M K Gately
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

View more
  36 in total

1.  Innate lymphoid cell disturbance with increase in ILC1 in systemic lupus erythematosus.

Authors:  Chaohuan Guo; Mianjing Zhou; Siyuan Zhao; Yuefang Huang; Shuang Wang; Rong Fu; Mengyuan Li; Tengyue Zhang; Felicia Gaskin; Niansheng Yang; Shu Man Fu
Journal:  Clin Immunol       Date:  2019-03-26       Impact factor: 3.969

2.  Monocytes from Irf5-/- mice have an intrinsic defect in their response to pristane-induced lupus.

Authors:  Lisong Yang; Di Feng; Xiaohui Bi; Rivka C Stone; Betsy J Barnes
Journal:  J Immunol       Date:  2012-08-29       Impact factor: 5.422

Review 3.  New therapies for systemic lupus erythematosus.

Authors:  F Goldblatt; D A Isenberg
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

Review 4.  Systemic lupus erythematosus biomarkers: the challenging quest.

Authors:  Cristina Arriens; Jonathan D Wren; Melissa E Munroe; Chandra Mohan
Journal:  Rheumatology (Oxford)       Date:  2017-04-01       Impact factor: 7.580

5.  Proinflammatory adaptive cytokine and shed tumor necrosis factor receptor levels are elevated preceding systemic lupus erythematosus disease flare.

Authors:  Melissa E Munroe; Evan S Vista; Joel M Guthridge; Linda F Thompson; Joan T Merrill; Judith A James
Journal:  Arthritis Rheumatol       Date:  2014-07       Impact factor: 10.995

Review 6.  The multi-faceted influences of estrogen on lymphocytes: toward novel immuno-interventions strategies for autoimmunity management.

Authors:  Ebru Karpuzoglu; Moncef Zouali
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

Review 7.  Cytokines in systemic lupus erythematosus.

Authors:  Elaine V Lourenço; Antonio La Cava
Journal:  Curr Mol Med       Date:  2009-04       Impact factor: 2.222

8.  Association of estrogen receptor alpha gene polymorphisms with cytokine genes expression in systemic lupus erythematosus.

Authors:  Zhi-Ming Lu; Zi-E Wang; Yi-Qing Liu; Chun-Xiao Wu; Chang-Yin Wang; Bing-Chang Zhang; Song Shao; Yu-Lian Jiao; Zhi-Xiang Che; Zi-Jiang Chen; Yue-Ran Zhao
Journal:  Croat Med J       Date:  2009-04       Impact factor: 1.351

9.  Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritis.

Authors:  M Tucci; L Lombardi; H B Richards; F Dammacco; F Silvestris
Journal:  Clin Exp Immunol       Date:  2008-09-15       Impact factor: 4.330

10.  Cutaneous warts in patients with lupus erythematosus.

Authors:  Cengiz Korkmaz; S Murat Urer
Journal:  Rheumatol Int       Date:  2003-09-11       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.